ウェビナーアーカイブ
- ホーム
- ウェビナーアーカイブ
-
パネルディスカッション： Current & Future Realities of mRNA Process Development
Jeff Atkinson, Ph.D.※1, James Nolan※2, Khaled Yamout※3
※1 Vice President, Technical Operations, Omega Therapeutics
※2 Vice President, Head of Technical Operations, Sail Biomedicines
※3 Analytical Sciences, Quality, Development & Manufacturing, Consultant -
「細胞療法および移植のための最大限の安全性と治療効果を発揮する強力なツール」
Powerful tools for maximum safety and curative cell for cell therapy and transplant
Prof. Shusen Wang※1, Dr. Gumpei Yoshimatsu※2, Prof. Po-Wei Lee※3
※1 Director of Cell Transplant Department, Tianjin First Central Hospital, China
※2 MD, PhD, Director for Regenerative Center, Associate Professor, Fukuoka University, Japan
※3 Director, BioGend Therapeutics, Taiwan -
パネルディスカッション：Opening the “Black Box” of the mRNA regulatory paradigm
Melanie Cerullo※1, Oreanna Thomas※2, Ye Zhang※3,
※1 Chief Quality & Regulatory Officer, ReciBioPharm
※2 Associate Director, Nutcracker Therapeutics
※3 Chief Regulatory Officer, Arcturus Therapeutics -
Evaluation of current & advanced analytical technologies for the comprehensive characterization of mRNA and its impurities
Axel Guilbaud
Principal Scientist, Genentech
-
The Current State of Molecular Diagnostics for Respiratory Infections (Free virtual roundtable)
-
Exploring the Molecular Diagnostics with RNA enzymes
Dr. JinSeok Kang※1, Ms. Teoh Hui Kee※2
※1 CEO, Co-founder, iGENETECH, Republic of Korea
※2 Laboratory Manager, Vivantis Technologies, Malaysia -
Important Decisions for mRNA Vaccines and Therapeutics Development
Dr. Piao Xijun※1, Dr. Rena Akahori※2
※1 Vice President, Head of mRNA Process Development, CATUG Biotechnology, China
※2 Scientist, CMC Development Group, ARCALIS INC, Japan -
mRNAワクチンおよび医薬品の現状と今後の展望(2022年版）
位髙 啓史 先生※1、中島 和幸 様※2
※1 東京医科歯科大学 生体材料工学研究所 生体材料機能医学分野 教授
※2 株式会社ARCALIS CMC開発部 ヘッド
※ご視聴には会員登録（無料）が必要です -
Optimizing Upstream Process with Metabolite Testing and Cell Analysis
Dr. Hang Zhou※1, Dr. Christian Weilke※2
※1 Vice President, Head of Cell Culture Process Development, WuXi Biologics, China
※2 Director International Product Management CustomBiotech, Roche Diagnostics GmbH -
Developing Better Quality Controls in Advanced Therapy Medicinal Product (ATMP)
Dr Masayo Takahashi※1, Mr Philipp Müller※2
※1 President, Vision Care Inc. Japan
※2 Specialist Manager for Molecular Biology, Labor LS Germany